国浩律师（杭州）事务所 关 于 地址：杭州市上城区老复兴路白塔公园 B 区 2 号、15 号国浩律师 楼 邮编：310008 Grandall Building, No.2＆No.15, Block B, Baita Park, Old Fuxing Road, Hangzhou, Zhejiang 310008, China 电话/Tel: (+86)(571) 8577 5888 传真/Fax: (+86)(571) 8577 5643 电子邮箱/Mail：grandallhz@grandall.com.cn 网址/Website：http://www.grandall.com.cn 顾家家居股份有限公司 差异化分红事项 之 专项法律意见书 二〇二五年六月 国浩律师（杭州）事务所 顾家家居差异化分红事项法律意见书 国浩律师（杭州）事务所 关 于 顾家家居股份有限公司 差异化分红事项 之 专项法律意见书 致：顾家家居股份有限公司 国浩律师（杭州）事务所接受顾家家居股份有限公司（以下简称"顾家家居" 或"公司"）的委托，根据《中华人民共和国公司法》 （以下简称"《公司法》"）、 本法律意见书仅对顾家家居 20 ...

智通财经6月26日电，据央视新闻，以色列国防军总参谋长扎米尔25日在视频讲话中表示，经过12天的 战斗，以色列国防军已"完全实现了此次行动的目标"。他表示，根据以军高级情报官员的评估，伊朗核 计划遭受的损害并非局部损害，而是"系统性损害"，这使得伊朗核计划"倒退了数年"。他强调，以色列 不会允许伊朗生产大规模杀伤性武器。 以军总参谋长：伊朗核计划遭受了"系统性损害" ...

企业名称江苏陶固节能新材料科技有限公司法定代表人侯南南注册资本2000万人民币国标行业制造业> 非金属矿物制品业>石墨及其他非金属矿物制品制造地址江苏省徐州市睢宁县庆安镇251省道东侧、东 楼社区境内园满创智科技园36号企业类型有限责任公司营业期限2025-6-25至无固定期限登记机关睢宁 县行政审批局 来源：金融界 天眼查App显示，近日，江苏陶固节能新材料科技有限公司成立，法定代表人为侯南南，注册资本2000 万人民币，朗威（天津）咨询有限公司、山东鼎字节能科技有限公司持股。 序号股东名称持股比例1朗威（天津）咨询有限公司70%2山东鼎字节能科技有限公司30% 经营范围含许可项目：建设工程施工（除核电站建设经营、民用机场建设）（依法须经批准的项目，经 相关部门批准后方可开展经营活动，具体经营项目以审批结果为准）技术服务、技术开发、技术咨询、 技术交流、技术转让、技术推广；新材料技术研发；耐火材料生产；耐火材料销售；新型陶瓷材料销 售；隔热和隔音材料销售；保温材料销售；建筑材料销售；五金产品批发；五金产品零售；金属制品销 售；建筑陶瓷制品销售；机械设备销售；数控机床销售；金属材料销售；建筑用钢筋产品销售；风 ...

金十数据6月26日讯，据AXIOS报道，四位消息人士透露，特朗普政府计划限制与国会共享机密信息， 此前有人泄露了一份内部评估，显示周六对伊朗核设施的轰炸并未像特朗普声称的那样成功。消息人士 称，联邦调查局也在调查这起泄密事件。国防情报局（DIA）初步"战斗损伤评估报告"的泄露激怒了特 朗普和美国高级官员。他们表示，该评估不完整，其发布旨在削弱特朗普关于伊朗核设施已被"彻底摧 毁"的说法。消息人士表示，他们计划限制在CAPNET（政府用于与国会共享机密信息的系统）上的信 息发布。DIA关于伊朗轰炸的评估于周一晚些时候上传至CAPNET。次日下午，CNN和《纽约时报》先 后报道了该评估的片段。 特朗普政府因伊朗轰炸评估泄露拟限制国会机密共享 ...

高盛已将2025年下半年伦敦金属交易所(LME)铜价预测上调至平均9890美元，高于此前的9140美元，预 计铜价到今年12月将下跌至9700美元；2025年铜价有望达到每吨10,050美元的峰值。预计2026年铜价全 年均价为每吨10,000美元(此前预测为10,170美元)，并预计到2026年12月将达到10,350美元。(智通财经) ...

以色列航空计划下周起恢复所有目的地常规航班 智通财经6月26日电，据央视新闻，当地时间25日，以色列航空宣布重新开放销售其所有航线的机票， 并计划从下周起恢复所有目的地的常规航班。 ...

Core Insights - Amphenol (APH) and Bel Fuse (BELFB) are prominent manufacturers of electrical and electronic products, with Amphenol focusing on connectors, interconnect systems, antennas, and cables, while Bel Fuse offers products that power, protect, and connect electronic circuits [1][2] Market Overview - The global electronic components market was valued at $393.63 billion in 2024 and is projected to grow to $847.88 billion by 2032, with a CAGR of 10.3% from 2025 to 2032, presenting significant growth opportunities for both companies [3] Amphenol (APH) Analysis - Amphenol's diversified business model reduces volatility across end markets and geographies, with strong demand in commercial aerospace and defense driving growth [4] - The company anticipates high-single-digit sequential sales growth in Q2 2025, supported by demand for jetliners and next-gen aircraft [4] - The increasing use of AI and machine learning is expected to enhance APH's long-term prospects in the IT datacom market [5] - Acquisitions have bolstered APH's product offerings, contributing 8% to 2024 revenues, with notable acquisitions including CIT and Lutze [6][7] - APH's acquisition of CommScope's Andrew business is projected to add approximately $0.09 to earnings in 2025, while the LifeSync acquisition enhances its medical interconnect product range [7] Bel Fuse (BELFB) Analysis - Bel Fuse also benefits from a diversified business model, with a backlog of orders reaching $395.7 million, up 4% sequentially, driven by strength in aerospace, defense, space, and AI [8] - However, Bel Fuse faces challenges from lower sales in the consumer market and elevated costs associated with the Enercon acquisition, impacting revenues [9][10] - The company is implementing cost-saving initiatives expected to materialize over the next 12 to 18 months [11] Stock Performance and Valuation - Year-to-date, APH shares have increased by 37.9%, outperforming BELFB's 12.1% rise [12] - Valuation metrics indicate APH shares are overvalued with a Value Score of D, while BELFB shares are considered cheap with a Value Score of B [15] - APH's forward 12-month Price/Sales ratio stands at 5.58X, significantly higher than BELFB's 1.82X [18] Earnings Estimates - The Zacks Consensus Estimate for APH's 2025 earnings is $2.68 per share, reflecting a 41.8% year-over-year increase [19] - For Bel Fuse, the consensus estimate for 2025 earnings is $6.05 per share, indicating an 84.45% year-over-year increase [20] Investment Outlook - Amphenol is viewed as a stronger investment option compared to Bel Fuse, benefiting from acquisitions and solid cash flow, while Bel Fuse is facing tariff-related challenges [21] - Amphenol holds a Zacks Rank 2 (Buy), while Bel Fuse has a Zacks Rank 3 (Hold) [22]

Core Insights - FedEx reported strong fourth-quarter fiscal 2025 results, beating both earnings and revenue estimates, but provided a dismal outlook, leading to a more than 5% drop in shares after market close [1][3] Financial Performance - Earnings per share for FedEx were $6.07, surpassing the Zacks Consensus Estimate of $5.93 and improving from $5.41 a year ago [3] - Revenues increased by 0.5% year over year to $22.2 billion, exceeding the consensus estimate of $21.7 billion [3] Future Outlook - For the first quarter of fiscal 2026, FedEx expects revenues to be flat or increase by up to 2%, with adjusted earnings per share projected between $3.40 and $4.00 [4] - The Zacks Consensus Estimate for revenues indicates a growth of 0.21%, while the estimate for earnings per share is $4.05 [4] - FedEx did not provide earnings and revenue forecasts for fiscal 2026 due to uncertainties surrounding U.S. trade policies, particularly with China [5] Cost Management - FedEx achieved its $4 billion cost-cutting goal and aims to trim an additional $1 billion in the upcoming fiscal year [5] ETF Impact - The sluggish trading is expected to affect ETFs with high allocations to FedEx, including ProShares Supply Chain Logistics ETF, iShares U.S. Transportation ETF, First Trust Nasdaq Transportation ETF, and Pacer Industrials and Logistics ETF [2] ETF Details - ProShares Supply Chain Logistics ETF holds 40 stocks, with FedEx accounting for 4.6% of assets, and has an asset base of $0.9 million [6][7] - iShares U.S. Transportation ETF includes 44 securities, with FedEx making up 4.5% of assets and has $657.1 million in AUM [8][9] - First Trust Nasdaq Transportation ETF tracks 38 transportation securities, with FedEx accounting for 3.6% of the basket and has an asset base of $28.4 million [10][11] - Pacer Industrials and Logistics ETF tracks 109 stocks, with FedEx representing 3.1% of the holdings and has accumulated $1.6 million in assets [12][13]

Core Viewpoint - Idorsia Ltd. successfully held bondholder meetings to approve amendments to the terms of its convertible bonds, extending their maturity dates significantly [1][2][3]. Group 1: Bondholder Meetings - Two bondholder meetings were conducted for Idorsia's CHF 200 million convertible bonds maturing in 2025 and CHF 600 million convertible bonds maturing in 2028 [2]. - The amendments include extending the maturity date of the CB 2025 to July 17, 2034, and the CB 2028 to August 4, 2038 [2]. Group 2: Voting Outcomes - A significant majority of 89.5% of CB 2025 holders and 93.5% of CB 2028 holders voted in favor of the amendments, surpassing the required two-thirds majority [3]. - The amendments will become binding upon approval by the higher cantonal composition authority and are contingent on the completion of the repurchase offer for both bonds [3]. Group 3: Company Overview - Idorsia Ltd. aims to challenge medical paradigms and develop transformative medicines, positioning itself as a leading biopharmaceutical company [6]. - The company is headquartered near Basel, Switzerland, and has a strong focus on small-molecule drug discovery [7].

Company Acquisition - The Akkermansia Company (TAC) has been acquired by Danone, a leading global food and beverage company [1] Product Development - TAC's founding scientists discovered the biotic strain Akkermansia muciniphila MucT in 2004, demonstrating its ability to reinforce the gut barrier, reduce inflammation, and counteract metabolic disorders such as obesity, diabetes, and cardiovascular disease [2] - The company holds broad patents protecting the use of the Akkermansia species, including the pasteurized version MucT, which is its most bio-efficacious form [2] Market Expansion - TAC is expanding its business into key markets in Europe, North America, and Asia, aiming to accelerate global growth of the pasteurized Akkermansia muciniphila MucT strain [3] - The CEO of TAC expressed excitement about joining Danone, highlighting the resources that will facilitate faster brand development [3] Vision and Goals - TAC's Chief Technology Officer emphasized the goal of providing billions of consumers with improved metabolic health through Akkermansia [4] - The company aims to shift the focus of microbiome health from symptoms to root causes, positioning itself as a leader in next-generation probiotic and postbiotic supplements [5]